WRF
GILD icon

Waddell & Reed Financial’s Gilead Sciences GILD Stock Holding History

Waddell & Reed Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,892
Closed -$466K – 477
2019
Q2 		$466K Buy
6,892
+875
+15% +$57.6K ﹤0.01% 461
2019
Q1 		$391K Sell
6,017
-745,490
-99% -$49.5M ﹤0.01% 472
2018
Q4 		$47M Sell
751,507
-712,950
-49% -$49.8M 0.13% 200
2018
Q3 		$113M Buy
1,464,457
+7,257
+0.5% +$548K 0.25% 114
2018
Q2 		$103M Hold
1,457,200
– – 0.24% 121
2018
Q1 		$110M Buy
1,457,200
+189,000
+15% +$15M 0.25% 109
2017
Q4 		$90.9M Buy
1,268,200
+408,100
+47% +$31M 0.2% 125
2017
Q3 		$69.7M Buy
860,100
+538,800
+168% +$41.2M 0.15% 164
2017
Q2 		$22.7M Buy
321,300
+1,300
+0.4% +$86.5K 0.05% 333
2017
Q1 		$21.7M Sell
320,000
-103,270
-24% -$7.26M 0.05% 339
2016
Q4 		$30.3M Sell
423,270
-36,030
-8% -$2.68M 0.07% 286
2016
Q3 		$36.3M Sell
459,300
-1,720,394
-79% -$140M 0.08% 250
2016
Q2 		$182M Sell
2,179,694
-1,401,064
-39% -$124M 0.38% 71
2016
Q1 		$329M Buy
3,580,758
+258,564
+8% +$23.3M 0.62% 49
2015
Q4 		$336M Buy
3,322,194
+29,033
+0.9% +$3.02M 0.55% 57
2015
Q3 		$323M Sell
3,293,161
-3,566,717
-52% -$396M 0.53% 52
2015
Q2 		$803M Sell
6,859,878
-936,141
-12% -$102M 1.15% 15
2015
Q1 		$765M Sell
7,796,019
-484,139
-6% -$49.2M 1.06% 19
2014
Q4 		$780M Buy
8,280,158
+951,497
+13% +$98.4M 1.08% 18
2014
Q3 		$780M Sell
7,328,661
-477,861
-6% -$46.8M 1.08% 20
2014
Q2 		$647M Sell
7,806,522
-3,097,407
-28% -$241M 0.95% 22
2014
Q1 		$773M Buy
10,903,929
+2,884,371
+36% +$226M 1.17% 14
2013
Q4 		$603M Buy
8,019,558
+1,543,429
+24% +$107M 0.97% 21
2013
Q3 		$407M Sell
6,476,129
-1,123,062
-15% -$67.1M 0.78% 37
2013
Q2 		$389M Buy
+7,599,191
New +$396M 0.81% 34

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Waddell & Reed Financial's GILD Position: Q3 2019 in Review

Waddell & Reed Financial sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 6,892 shares — an estimated $466K sold.

Waddell & Reed Financial first reported a position in GILD in Q2 2013 and held it in 25 quarters. The position peaked at $803M in Q2 2015. 1,463 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Waddell & Reed Financial reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
  • Waddell & Reed Financial sold 6,892 Gilead Sciences shares in Q3 2019, an estimated $466K.
  • Waddell & Reed Financial first reported a position in Gilead Sciences in Q2 2013 and held it in 25 quarters.
  • Waddell & Reed Financial's Gilead Sciences position peaked at $803M in Q2 2015.
  • 1,463 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Waddell & Reed Financial's 13F filing for Q3 2019, filed 14 Nov 2019.